Literature DB >> 32877614

Cigarillos Compromise the Mucosal Barrier and Protein Expression in Airway Epithelia.

Sabri H Abdelwahab1,2, Boris Reidel1,2, Jessica R Martin2, Arunava Ghosh2, James E Keating3, Prashamsha Haridass1,2, Jerome Carpenter1,2, Gary L Glish3, Robert Tarran2,4, Claire M Doerschuk1,2,5, Mehmet Kesimer1,2.   

Abstract

Smoking remains a leading cause of preventable morbidity and mortality worldwide. Despite a downward trend in cigarette use, less-regulated tobacco products, such as cigarillos, which are often flavored to appeal to specific demographics, such as younger people, are becoming increasingly popular. Cigar/cigarillo smoking has been considered a safer alternative to cigarettes; however, the health risks associated with cigar in comparison with cigarette smoking are not well understood. To address this knowledge gap, we characterized the effects of multiple brands of cigarillos on the airway epithelium using ex vivo and in vivo models. To analyze these effects, we assessed the cellular viability and integrity of smoke-exposed primary airway cell cultures. We also investigated the protein compositions of apical secretions from cigarillo-exposed airway epithelial cultures and BAL fluid of cigarillo-exposed mice through label-free quantitative proteomics and determined the chemical composition of smoke collected from the investigated cigarillo products. We found that cigarillo smoke exerts similar or greater effects than cigarette smoke in terms of reduced cell viability; altered protein levels, including those of innate immune proteins; induced oxidative-stress markers; and greater nicotine delivery to cells. The analysis of the chemical composition of the investigated cigarillo products revealed differences that might be linked to the differential effects of these products on cell viability and protein abundance profiles, which have been associated with a range of health risks in the context of airway biology. These findings contradict the assumption that cigarillos might be safer and less harmful than cigarettes. Instead, our results indicate that cigarillo smoke is associated with equal or greater health risks and the same or increased airway toxicity compared with cigarette smoke.

Entities:  

Keywords:  airways; cigarillo; smoking harm

Mesh:

Substances:

Year:  2020        PMID: 32877614      PMCID: PMC7790145          DOI: 10.1165/rcmb.2019-0085OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  53 in total

1.  The Relationship of Mucus Concentration (Hydration) to Mucus Osmotic Pressure and Transport in Chronic Bronchitis.

Authors:  Wayne H Anderson; Raymond D Coakley; Brian Button; Ashley G Henderson; Kirby L Zeman; Neil E Alexis; David B Peden; Eduardo R Lazarowski; C William Davis; Summer Bailey; Fred Fuller; Martha Almond; Bahjat Qaqish; Elena Bordonali; Michael Rubinstein; William D Bennett; Mehmet Kesimer; Richard C Boucher
Journal:  Am J Respir Crit Care Med       Date:  2015-07-15       Impact factor: 21.405

2.  TrendBlendz: how Splitarillos use marijuana flavours to promote cigarillo use.

Authors:  Ganna Kostygina; Jidong Huang; Sherry Emery
Journal:  Tob Control       Date:  2016-04-06       Impact factor: 7.552

Review 3.  The innate immune system in cystic fibrosis lung disease.

Authors:  R Bals; D J Weiner; J M Wilson
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

Review 4.  Pulmonary surfactant-associated proteins.

Authors:  T E Weaver
Journal:  Gen Pharmacol       Date:  1988

5.  Cigarette smoke effects on innate immune mechanisms in the nasal mucosa. Potential effects on the microbiome.

Authors:  Ilona Jaspers
Journal:  Ann Am Thorac Soc       Date:  2014-01

Review 6.  Mucins, mucus, and sputum.

Authors:  Judith A Voynow; Bruce K Rubin
Journal:  Chest       Date:  2009-02       Impact factor: 9.410

7.  Flavored little cigar smoke induces cytotoxicity and apoptosis in airway epithelia.

Authors:  Arunava Ghosh; Rachel C Nethery; Amy H Herring; Robert Tarran
Journal:  Cell Death Discov       Date:  2017-04-24

Review 8.  Inflammatory responses and inflammation-associated diseases in organs.

Authors:  Linlin Chen; Huidan Deng; Hengmin Cui; Jing Fang; Zhicai Zuo; Junliang Deng; Yinglun Li; Xun Wang; Ling Zhao
Journal:  Oncotarget       Date:  2017-12-14

9.  Role of breast regression protein 39 (BRP-39)/chitinase 3-like-1 in Th2 and IL-13-induced tissue responses and apoptosis.

Authors:  Chun Geun Lee; Dominik Hartl; Gap Ryol Lee; Barbara Koller; Hiroshi Matsuura; Carla A Da Silva; Myung Hyun Sohn; Lauren Cohn; Robert J Homer; Alexander A Kozhich; Alison Humbles; Jennifer Kearley; Anthony Coyle; Geoffrey Chupp; Jennifer Reed; Richard A Flavell; Jack A Elias
Journal:  J Exp Med       Date:  2009-05-04       Impact factor: 14.307

Review 10.  Clinical issues of mucus accumulation in COPD.

Authors:  Frederick L Ramos; Jason S Krahnke; Victor Kim
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2014-01-24
View more
  3 in total

1.  Assembly and organization of the N-terminal region of mucin MUC5AC: Indications for structural and functional distinction from MUC5B.

Authors:  Jerome Carpenter; Yang Wang; Richa Gupta; Yuanli Li; Prashamsha Haridass; Durai B Subramani; Boris Reidel; Lisa Morton; Caroline Ridley; Wanda K O'Neal; Marie-Pierre Buisine; Camille Ehre; David J Thornton; Mehmet Kesimer
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-28       Impact factor: 11.205

2.  Update in Chronic Obstructive Pulmonary Disease 2020.

Authors:  Andy I Ritchie; Jonathon R Baker; Trisha M Parekh; James P Allinson; Surya P Bhatt; Louise E Donnelly; Gavin C Donaldson
Journal:  Am J Respir Crit Care Med       Date:  2021-07-01       Impact factor: 21.405

3.  Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.

Authors:  Giorgia Radicioni; Agathe Ceppe; Amina A Ford; Neil E Alexis; R Graham Barr; Eugene R Bleecker; Stephanie A Christenson; Christopher B Cooper; MeiLan K Han; Nadia N Hansel; Annette T Hastie; Eric A Hoffman; Richard E Kanner; Fernando J Martinez; Esin Ozkan; Robert Paine; Prescott G Woodruff; Wanda K O'Neal; Richard C Boucher; Mehmet Kesimer
Journal:  Lancet Respir Med       Date:  2021-05-28       Impact factor: 102.642

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.